Delighted to see the role of pharmacists in optimising and implementing heart failure therapies recognised in the latest ESC HF guideline update. A privilege to have played a small part in building this evidence base
#ESCcongress#ESC2026#HFpharmacists
❤️ What gets in the way of taking medicines?
New EJHP research evaluates the Making Medicines Work for You Screener to identify medication adherence barriers in heart failure.
🔗 https://t.co/A7y0Ejok2T
@EJHP_BMJ#EAHP2026#HeartFailure#MedicationAdherence #PatientCentredCare #ClinicalPharmacy
NICE have released their updated guidance on Heart Failure (NG106), bringing key changes to improve care and outcomes for people living with HF, and support clinicians in delivering this care.
Find the guidance here: https://t.co/NYeIYR54H3
There are several positive developments in the guidance including:
1. NICE recognise and name HF pharmacists as core to HF team.
2. Four pillars HF therapy recommended for HFrEF and 4 pillars to be considered for HFmrEF patients. A stepwise approach is no longer required. Use the person's clinical status to decide how and when to optimise medicine doses
3. Two pillars recognised for HFpEF (MRA and SGLT2-)
4. ARNI can now be initiated in primary care (but GPs should consider seeking specialist HF advice first).
5. NICE recommends iv iron in HFrEF with iron deficiency (if Hb <150g/l, TSAT <20% OR ferritin <100ng/l).
This is a positive step in the right direction for heart failure care and treatment but we must continue to work together to advocate for further improvements and ensure heart failure becomes a national priority.
#25in25 #HeartFailure #NICEGuidance
It's been an honour to have been the pharmacist representative on this NICE HF guideline update. There are a number of new important recommendations that will help to ensure HF patients receive guideline directed therapy.
We’ve published our updated clinical guideline on the diagnosis and management of chronic heart failure. You can see what’s new here: https://t.co/Oym2jguXFQ
A privilege to have worked as a member of the
@NICEComms
guidelines committee with 3 cardiologists, 2 Care of the Elderly physicians, 1 HFSN, 1 nephrologist, 3 GPs, 1 pharmacist, 2 patient representatives and a wonderful technical team on these #HF guidelines
@BSHeartFailure
@DiaGreenBelle Our HF MDT is very supportive, which has been key to helping reduce barriers. It's taken a team approach to identify how HF pharmacists can be best utilised, and there are more improvements to be made. Importantly, patient satisfaction with these clinics is high.
‘Implementation and evaluation of specialist heart failure pharmacist prescribing clinics’
@IntJClinPharm
@ESCPNews Best Practice
@GayleLCampbell
https://t.co/O2mFWBUdGY
I'm absolutely delighted to say I've passed the RPS consultant pharmacist credentialing process in heart failure. It wouldn't have been possible without the support of so many colleagues and patients. Thank you! #heartfailure#pharmacist#rps
Is our current pharmacy workforce model fit for purpose?
Read our values-based argument as to why we believe it isnt & why we all need to work together & replace it with something new & more dynamic: The Collaborative Care Model @RSAPjournal
https://t.co/MRTBGrC2rM
🧵
1/25